基本資料
種類: ETF
費用比率%: 0.09
資產淨值: 6,452.81
成立日期: 26/01/2004
 
分析
市值分佈:
96.57%
大市值
2.18%
中市值
0.62%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 11/11/2026 04:01) 總持有投資項目: 410  
0%
 
100%
     10大 (51.75%)
代號 名稱 佔比% ▼ 持有日期
ORICOric Pharmaceuticals0.0130/09/2026
CGEMCullinan Therapeutics0.0130/09/2026
GERNGeron Corp0.0130/09/2026
CRMDCorMedix0.0130/09/2026
BVSBioventus0.0130/09/2026
ANGOAngioDynamics0.0130/09/2026
GLUEMonte Rosa Therapeutics0.0130/09/2026
CBLLCERIBELL INC0.0130/09/2026
MDXGMiMedx Group0.0130/09/2026
FDMT4D Molecular Therapeutics0.0130/09/2026
AURAAura Biosciences0.0130/09/2026
BCAXBicara Therapeutics Inc.0.0130/09/2026
MLTXMoonLake Immunotherapeutics0.0130/09/2026
DNAGinkgo Bioworks Holdings0.0130/09/2026
ANNXAnnexon0.0130/09/2026
PHRPhreesia0.0130/09/2026
SANASana Biotechnology0.0130/09/2026
AHCOAdaptHealth Corp0.0130/09/2026
TCMDTactile Systems Technology0.0130/09/2026
STTKShattuck Labs0.0130/09/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13    14    15   16    17    18    19    20    21  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.